Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Emerging Biomarkers of Oxidative Stress in Acute and Stable Coronary Artery Disease: Levels and Determinants.

Lubrano V, Pingitore A, Traghella I, Storti S, Parri S, Berti S, Ndreu R, Andrenelli A, Palmieri C, Iervasi G, Mastorci F, Vassalle C.

Antioxidants (Basel). 2019 May 1;8(5). pii: E115. doi: 10.3390/antiox8050115.

2.

[Treatment of patients with brain metastases from a melanoma].

Modesto A, Chira C, Sol JC, Lubrano V, Boulinguez S, Pagès C, Sibaud V, Gomez-Roca C, Moyal É, Meyer N.

Cancer Radiother. 2019 Apr;23(2):147-150. doi: 10.1016/j.canrad.2018.05.006. Epub 2019 Mar 21. Review. French.

PMID:
30904418
3.

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.

BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.

4.

RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.

Boyrie S, Delmas C, Lemarié A, Lubrano V, Dahan P, Malric L, Luis J, Gilhodes J, Tosolini M, Mouly L, Lehmann M, Toulas C, Cohen-Jonathan Moyal E, Monferran S.

Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082. eCollection 2018 Sep 18.

5.

Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.

Malric L, Monferran S, Delmas C, Arnauduc F, Dahan P, Boyrie S, Deshors P, Lubrano V, Da Mota DF, Gilhodes J, Filleron T, Siegfried A, Evrard S, Kowalski-Chauvel A, Moyal EC, Toulas C, Lemarié A.

Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.

PMID:
30266751
6.

FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker.

Gouazé-Andersson V, Ghérardi MJ, Lemarié A, Gilhodes J, Lubrano V, Arnauduc F, Cohen-Jonathan Moyal E, Toulas C.

Oncotarget. 2018 Aug 3;9(60):31637-31649. doi: 10.18632/oncotarget.25827. eCollection 2018 Aug 3.

7.

Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.

Freyschlag CF, Krieg SM, Kerschbaumer J, Pinggera D, Forster MT, Cordier D, Rossi M, Miceli G, Roux A, Reyes A, Sarubbo S, Smits A, Sierpowska J, Robe PA, Rutten GJ, Santarius T, Matys T, Zanello M, Almairac F, Mondot L, Jakola AS, Zetterling M, Rofes A, von Campe G, Guillevin R, Bagatto D, Lubrano V, Rapp M, Goodden J, De Witt Hamer PC, Pallud J, Bello L, Thomé C, Duffau H, Mandonnet E.

J Neurooncol. 2018 Sep;139(3):699-711. doi: 10.1007/s11060-018-2916-3. Epub 2018 Jul 10.

8.

LOX-1 receptor: A potential link in atherosclerosis and cancer.

Balzan S, Lubrano V.

Life Sci. 2018 Apr 1;198:79-86. doi: 10.1016/j.lfs.2018.02.024. Epub 2018 Feb 17. Review.

PMID:
29462603
9.

Angiopoietin-2: a biomarker in hyperthyroidism.

Ndreu R, Lubrano V, Sabatino L, Ripoli A, Iervasi G, Balzan S.

Theor Biol Forum. 2018 Jan 1;111(1-2):57-66. doi: 10.19272/201811402005.

PMID:
31089669
10.
11.

Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.

Attal J, Chaltiel L, Lubrano V, Sol JC, Lanaspeze C, Vieillevigne L, Latorzeff I, Cohen-Jonathan Moyal E.

J Neurooncol. 2018 Jan;136(2):413-419. doi: 10.1007/s11060-017-2669-4. Epub 2017 Dec 22.

PMID:
29273890
12.

Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects.

Vassalle C, Masotti S, Lubrano V, Basta G, Prontera C, Di Cecco P, Del Turco S, Sabatino L, Pingitore A.

Eur J Appl Physiol. 2018 Feb;118(2):411-417. doi: 10.1007/s00421-017-3783-x. Epub 2017 Dec 18.

PMID:
29256048
13.

Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.

Tensaouti F, Khalifa J, Lusque A, Plas B, Lotterie JA, Berry I, Laprie A, Cohen-Jonathan Moyal E, Lubrano V.

Neuroradiology. 2017 Oct;59(10):1013-1020. doi: 10.1007/s00234-017-1899-7. Epub 2017 Aug 25.

PMID:
28842741
14.

A fermented bean flour extract downregulates LOX-1, CHOP and ICAM-1 in HMEC-1 stimulated by ox-LDL.

Gabriele M, Pucci L, La Marca M, Lucchesi D, Della Croce CM, Longo V, Lubrano V.

Cell Mol Biol Lett. 2016 Aug 12;21:10. doi: 10.1186/s11658-016-0015-z. eCollection 2016.

15.

Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol.

Rofes A, Mandonnet E, Godden J, Baron MH, Colle H, Darlix A, de Aguiar V, Duffau H, Herbet G, Klein M, Lubrano V, Martino J, Mathew R, Miceli G, Moritz-Gasser S, Pallud J, Papagno C, Rech F, Robert E, Rutten GJ, Santarius T, Satoer D, Sierpowska J, Smits A, Skrap M, Spena G, Visch E, De Witte E, Zetterling M, Wager M.

Acta Neurochir (Wien). 2017 Jul;159(7):1167-1178. doi: 10.1007/s00701-017-3192-2. Epub 2017 May 4.

PMID:
28474122
16.

Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database.

Terrier LM, Bauchet L, Rigau V, Amelot A, Zouaoui S, Filipiak I, Caille A, Almairac F, Aubriot-Lorton MH, Bergemer-Fouquet AM, Bord E, Cornu P, Czorny A, Dam Hieu P, Debono B, Delisle MB, Emery E, Farah W, Gauchotte G, Godfraind C, Guyotat J, Irthum B, Janot K, Le Reste PJ, Liguoro D, Loiseau H, Lot G, Lubrano V, Mandonnet E, Menei P, Metellus P, Milin S, Muckenstrum B, Roche PH, Rousseau A, Uro-Coste E, Vital A, Voirin J, Wager M, Zanello M, François P, Velut S, Varlet P, Figarella-Branger D, Pallud J, Zemmoura I; Club de Neuro-Oncologie of the Société Française de Neurochirurgie.

Neuro Oncol. 2017 May 1;19(5):678-688. doi: 10.1093/neuonc/now186.

17.

Subventricular zones: new key targets for glioblastoma treatment.

Khalifa J, Tensaouti F, Lusque A, Plas B, Lotterie JA, Benouaich-Amiel A, Uro-Coste E, Lubrano V, Cohen-Jonathan Moyal E.

Radiat Oncol. 2017 Apr 20;12(1):67. doi: 10.1186/s13014-017-0791-2.

18.

fMRI study of graduated emotional charge for detection of covert activity using passive listening to narratives.

Sontheimer A, Vassal F, Jean B, Feschet F, Lubrano V, Lemaire JJ.

Neuroscience. 2017 May 4;349:291-302. doi: 10.1016/j.neuroscience.2017.02.048. Epub 2017 Feb 27.

19.

Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study.

Ursu R, Carpentier A, Metellus P, Lubrano V, Laigle-Donadey F, Capelle L, Guyotat J, Langlois O, Bauchet L, Desseaux K, Tibi A, Chinot O, Lambert J, Carpentier AF.

Eur J Cancer. 2017 Mar;73:30-37. doi: 10.1016/j.ejca.2016.12.003. Epub 2017 Jan 28.

PMID:
28142059
20.

Lectin-Like Oxidized Low-Density Lipoprotein Receptor (Lox-1), Thyroid Hormone (T3) And Reactive Oxygen Species (Ros): Possible Cross-Talk In Angiogenesis.

Balzan S, Sabatino L, Lubrano V.

Theor Biol Forum. 2017 Jan 1;110(1-2):13-23. doi: 10.19272/201711402002.

PMID:
29687829
21.

IMPACT OF RISK FACTOR FOR ATHEROSCLEROSIS ON MICROVASCULAR ENDOTHELIAL FUNCTION: AN IN VITRO STUDY.

Lubrano V, Venturi E, Balzan S, Baldi S, Natali A.

Theor Biol Forum. 2015;108(1-2):75-88.

PMID:
27167911
22.

Roles of LOX-1 in microvascular dysfunction.

Lubrano V, Balzan S.

Microvasc Res. 2016 May;105:132-40. doi: 10.1016/j.mvr.2016.02.006. Epub 2016 Feb 18. Review.

PMID:
26907636
23.

Enzymatic antioxidant system in vascular inflammation and coronary artery disease.

Lubrano V, Balzan S.

World J Exp Med. 2015 Nov 20;5(4):218-24. doi: 10.5493/wjem.v5.i4.218. eCollection 2015 Nov 20. Review.

24.

Cardiac involvement in Erdheim- Chester disease: MRI findings and literature revision.

Ponsiglione A, Puglia M, Barbuto L, Solla R, Altiero M, Lubrano V, Imbriaco M.

Acta Radiol Open. 2015 Sep 7;4(9):2058460115592273. doi: 10.1177/2058460115592273. eCollection 2015 Sep.

25.

Is there any benefit from short-term perioperative antiepileptic prophylaxis in patients with chronic subdural haematoma? A retrospective controlled study.

Battaglia F, Plas B, Melot A, Noudel R, Sol JC, Roche PH, Lubrano V.

Neurochirurgie. 2015 Oct;61(5):324-8. doi: 10.1016/j.neuchi.2015.06.004. Epub 2015 Aug 6.

PMID:
26256569
26.

Relationship among IL-6, LDL cholesterol and lipid peroxidation.

Lubrano V, Gabriele M, Puntoni MR, Longo V, Pucci L.

Cell Mol Biol Lett. 2015 Jun;20(2):310-22. doi: 10.1515/cmble-2015-0020.

PMID:
26204410
27.

Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.

Ken S, Deviers A, Filleron T, Catalaa I, Lotterie JA, Khalifa J, Lubrano V, Berry I, Péran P, Celsis P, Moyal EC, Laprie A.

J Neurooncol. 2015 Sep;124(3):465-73. doi: 10.1007/s11060-015-1860-8. Epub 2015 Jul 19.

PMID:
26189058
28.

Consolidated and emerging inflammatory markers in coronary artery disease.

Lubrano V, Balzan S.

World J Exp Med. 2015 Feb 20;5(1):21-32. doi: 10.5493/wjem.v5.i1.21. eCollection 2015 Feb 20. Review.

29.

Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.

Dahan P, Martinez Gala J, Delmas C, Monferran S, Malric L, Zentkowski D, Lubrano V, Toulas C, Cohen-Jonathan Moyal E, Lemarie A.

Cell Death Dis. 2014 Nov 27;5:e1543. doi: 10.1038/cddis.2014.509.

30.

Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones.

Sabatino L, Lubrano V, Balzan S, Kusmic C, Del Turco S, Iervasi G.

Mol Cell Biochem. 2015 Jan;399(1-2):87-94. doi: 10.1007/s11010-014-2235-8. Epub 2014 Oct 11.

PMID:
25304215
31.

[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines].

Lubrano V, Derrey S, Truc G, Mirabel X, Thariat J, Cupissol D, Sassolas B, Combemale P, Modiano P, Bedane C, Dygai-Cochet I, Lamant L, Mourrégot A, Rougé Bugat MÈ, Siegrist S, Tiffet O, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT; Institut nationalducancer.

Neurochirurgie. 2014 Dec;60(6):269-75. doi: 10.1016/j.neuchi.2014.05.002. Epub 2014 Sep 17. French.

PMID:
25241016
32.

Innovative approach to interpret the variability of biomarkers after ultra-endurance exercise: the multifactorial analysis.

Vassalle C, Piaggi P, Weltman N, Prontera C, Garbella E, Menicucci D, Lubrano V, Piarulli A, Castagnini C, Passera M, Pellegrini S, Metelli MR, Bedini R, Gemignani A, Pingitore A.

Biomark Med. 2014;8(6):881-91. doi: 10.2217/bmm.13.152.

PMID:
25224944
33.

Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.

Deviers A, Ken S, Filleron T, Rowland B, Laruelo A, Catalaa I, Lubrano V, Celsis P, Berry I, Mogicato G, Cohen-Jonathan Moyal E, Laprie A.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):385-93. doi: 10.1016/j.ijrobp.2014.06.009. Epub 2014 Aug 4.

PMID:
25104068
34.

α-1 Protein evaluation to stratify heart failure patients.

Lubrano V, Papa A, Pingitore A, Cocci F.

J Cardiovasc Med (Hagerstown). 2017 Oct;18(10):774-776. doi: 10.2459/JCM.0000000000000016. No abstract available.

PMID:
24911195
35.

LOX-1 and ROS, inseparable factors in the process of endothelial damage.

Lubrano V, Balzan S.

Free Radic Res. 2014 Aug;48(8):841-8. doi: 10.3109/10715762.2014.929122. Epub 2014 Jun 23. Review.

PMID:
24886290
36.

French collaborative group series on giant intracranial aneurysms: Current management.

Derrey S, Penchet G, Thines L, Lonjon M, David P, Bataille B, Emery E, Lubrano V, Laguarrigue J, Bresson D, Pelissou I, Irthum B, Lejeune JP, Proust F.

Neurochirurgie. 2015 Dec;61(6):371-7. doi: 10.1016/j.neuchi.2013.11.006. Epub 2014 Mar 16.

PMID:
24647149
37.

Interactions between immune, stress-related hormonal and cardiovascular systems following strenuous physical exercise.

Menicucci D, Piarulli A, Mastorci F, Sebastiani L, Laurino M, Garbella E, Castagnini C, Pellegrini S, Lubrano V, Bernardi G, Metelli M, Bedini R, L'abbate A, Pingitore A, Gemignani A.

Arch Ital Biol. 2013 Sep;151(3):126-36. doi: 10.4449/aib.v151i3.1523.

PMID:
24599630
38.

[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].

Leccia MT, Planchamp F, Sassolas B, Combemale P, Modiano P, Bedane C, Cupissol D, Derrey S, Dygai-Cochet I, Lamant L, Lubrano V, Mirabel X, Mourrégot A, Rougé Bugat ME, Siegrist S, Thariat J, Tiffet O, Truc G, Verdoni L, Mazeau-Woynar V.

Ann Dermatol Venereol. 2014 Feb;141(2):111-21. doi: 10.1016/j.annder.2013.10.055. Epub 2013 Dec 26. French. Erratum in: Ann Dermatol Venereol. 2014 May;141(5):404-5.

PMID:
24507205
39.

MRI with DWI helps in depicting rheumatoid meningitis.

Roques M, Tanchoux F, Calvière L, Cuinat L, Lubrano V, Uro-Coste E, Cognard C, Larrue V, Bonneville F.

J Neuroradiol. 2014 Oct;41(4):275-7. doi: 10.1016/j.neurad.2013.10.005. Epub 2014 Jan 7. No abstract available.

PMID:
24405686
40.

[Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

Sassolas B, Mourrégot A, Thariat J, Tiffet O, Dygai-Cochet I, Mirabel X, Truc G, Cupissol D, Modiano P, Combemale P, Bedane C, Derrey S, Lamant L, Lubrano V, Siegrist S, Rougé-Bugat MÈ, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT.

Bull Cancer. 2014 Jan 1;101(1):9-16. doi: 10.1684/bdc.2013.1868. French.

PMID:
24369290
41.

A prospective video-based observational and analytical approach to evaluate management during brain tumour surgery at a university hospital.

Couat JF, Cegarra J, Rodsphon T, Geeraerts T, Lelardeux C, Sol JC, Lagarrigue P, Minville V, Lubrano VF.

Neurochirurgie. 2013 Aug-Oct;59(4-5):142-8. doi: 10.1016/j.neuchi.2013.05.001. Epub 2013 Aug 13. Review.

42.

LOX-1, a new marker of risk and prognosis in coronary artery disease?

Lubrano V, Balzan S.

Mol Cell Biochem. 2013 Nov;383(1-2):223-30. doi: 10.1007/s11010-013-1770-z. Epub 2013 Aug 11. Review.

PMID:
23934117
43.

Outcomes after surgery for central neurocytoma: results of a French multicentre retrospective study.

Lubrano V, François P, Loundou A, Vasiljevic A, Roche PH; French Society of Neurosurgery.

Acta Neurochir (Wien). 2013 Jul;155(7):1261-9. doi: 10.1007/s00701-013-1732-y. Epub 2013 May 21.

PMID:
23689966
44.

αvβ3 Integrin and Fibroblast growth factor receptor 1 (FGFR1): Prognostic factors in a phase I-II clinical trial associating continuous administration of Tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma.

Ducassou A, Uro-Coste E, Verrelle P, Filleron T, Benouaich-Amiel A, Lubrano V, Sol JC, Delisle MB, Favre G, Ken S, Laprie A, De Porre P, Toulas C, Poublanc M, Cohen-Jonathan Moyal E.

Eur J Cancer. 2013 Jun;49(9):2161-9. doi: 10.1016/j.ejca.2013.02.033. Epub 2013 Apr 6.

PMID:
23566417
45.

Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost.

Ken S, Vieillevigne L, Franceries X, Simon L, Supper C, Lotterie JA, Filleron T, Lubrano V, Berry I, Cassol E, Delannes M, Celsis P, Cohen-Jonathan EM, Laprie A.

Radiat Oncol. 2013 Jan 2;8:1. doi: 10.1186/1748-717X-8-1.

46.

Anatomical correlates for category-specific naming of objects and actions: a brain stimulation mapping study.

Lubrano V, Filleron T, Démonet JF, Roux FE.

Hum Brain Mapp. 2014 Feb;35(2):429-43. doi: 10.1002/hbm.22189. Epub 2012 Sep 27.

PMID:
23015527
47.
48.

[Incidence and clinical impact of seizures after surgery for chronic subdural haematoma].

Battaglia F, Lubrano V, Ribeiro-Filho T, Pradel V, Roche PH.

Neurochirurgie. 2012 Aug;58(4):230-4. doi: 10.1016/j.neuchi.2012.04.002. Epub 2012 May 22. French.

PMID:
22626817
49.

Itraconazole inhibits HMEC-1 angiogenesis.

Del Carratore R, Carpi A, Beffy P, Lubrano V, Giorgetti L, Maserti BE, Carluccio MA, Simili M, Iervasi G, Balzan S.

Biomed Pharmacother. 2012 Jun;66(4):312-7. doi: 10.1016/j.biopha.2011.11.004. Epub 2011 Dec 21.

PMID:
22564244
50.

Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor.

Balzan S, Del Carratore R, Nicolini G, Beffy P, Lubrano V, Forini F, Iervasi G.

J Clin Endocrinol Metab. 2012 May;97(5):1763-70. doi: 10.1210/jc.2011-2146. Epub 2012 Mar 14.

PMID:
22419707

Supplemental Content

Loading ...
Support Center